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Abstract: CagA strains of H.pylori (Hp) are known to be associated with gastroduodenal diseases. Polymorphisms 
in inflammation related genes, such as cytokines and their receptors, were thought to partly determine the outcome 
of Hp infection and the progression of gastritis. It is supposed that interleukin 23 receptor (IL23R), a basic cytokine 
receptor in the inflammatory IL-17/IL-23 axis, may be related to gastritis. In the present study, we evaluated the 
association of IL23R +2199 rs10889677 polymorphism and cagA positivity with chronic gastritis. In addition, we 
studied the infiltration of polymorphonuclear (PMN) and mononuclear (MN) Leukocytes into surrounding tissues of 
corpus. Biopsies taken from the corpus of the patients were classified as two groups: Hp-infected and Hp-
uninfected. The severity of gastritis was graded from normal to severe, chronic gastritis and chronic active gastritis. 
Virulence factor, cagA, was evaluated using PCR and the polymorphism in IL23R was investigated by polymerase 
chain reaction-restriction fragment length polymorphism (PCR-RFLP). AA and AC carriers of IL23R +2199 
polymorphism, but not CC genotype in Hp-uninfected patients, were not associated with cellular infiltration and 
gastritis in both groups (p > 0.05). CagA positivity was significantly associated with increased risk of PMN (P= 
0.013), but not with MN infiltration (P= 0.069). Also gastritis was found to be associated with cagA positivity (P= 
0.044). Our results show decreased Hp infection probability in patients with CC genotype of 2199 +IL23R. 
According to the clinical and pathological features in Hp-infected group, IL23R polymorphism doesn't influence 
chronic gastritis and chronic active gastritis. 
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Introduction 
Hp is a spiral-shaped Gram negative flagellate 
bacterium that colonizes the gastric mucosa of 
approximately 50 % of the world's population (1, 2). 
Hp infection induces inflammation in gastric mucosa 
that involved in chronic gastritis (3, 4). Hp-associated 
inflammatory response is defined by an immense 
mucosal infiltration of macrophages, PMNs, T cells, 
and plasma cells (5, 6).Gastritis may progress to 
other steps Such as, gastric atrophy, intestinal 
metaplasia, and gastric cancer (7-9). It may also lead 
to precancerous lesions looking like monoclonal 
lymphocytic proliferation, lymphoid follicle (LF) 
development and later primary gastric lymphoma 
(PGL) which develop only in a portion of individual 
with gastritis because of multifactorial effects of host 
virulence and bacterial factors that vary among 
different racial and social groups (10). Among 
bacterial factors, studies in developed countries 
mention that cagA-Positive strains of Hp are more 
often associated to gastroduodenal diseases than 
cagA-negative strains (11-14); however this has not 
been proven in developing countries with a high 
widespread of Hp infection. Among host factors 
several inflammatory proteins including cytokines, 
growth factors, and chemokines have been known to 
control adaptive immune response in contrast to Hp 
infection (15, 16). Firstly, El-Omar was reported an 
association between gastric cancer risk and 
interleukin 1 gene cluster polymorphisms (17). 
Studies from the western world show roles of anti- 
and pro- inflammatory cytokine genes such as 
Interleukin-1 beta (IL-1β), Interleukin 1 receptor 
antagonist (IL-1RN), Interleukin-10 (IL-10), and 
tumor necrosis factor alpha (TNF-α) gene 
polymorphisms affect risk in gastritis (18) and 
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precursors (17, 19). However Asian studies did not 
find any such association (20-22). IL-23 is a 
heterodimeric cytokine composed of the p40 and p19 
in which p40 is the common subunit shared with 
Interleukin-12 (IL-12) and p19 is the special subunit 
with a higher affinity to IL-23R (23).The locus of 
IL23R gene is on chromosome 1p31 and encodes a 
subunit of the IL-23 R. The heterodimeric IL-23R 
compound composed of IL-23R subunit associate 
with the IL-12Rβ1 subunit shared with the IL-12R 
complex. One of the most studied polymorphism in 
IL23R gene is R381Q (rs11209026) is located in the 
coding sequence of the IL23R and interchange 
arginine to glutamine in codon 381 (24). Recently, an 
inflammation pathway of IL-23/IL-17 axis reported 
to play fundamental role in inflammatory and 
autoimmune diseases(25), such as psoriasis (26), 
lupus nephritis(27), and intestinal inflammation (28). 
The new delineated pathway IL-23/IL-17 has proved 
to be included in the etiology of several chronic 
inflammatory diseases such as inflammatory bowel 
disease (IBD) (29), and ankylosing spondylitis. In 
addition, there is high level experssion of IL-23 in 
Hp-infected gastric mucosa (30). IL-23R, as the key 
component to IL-23R, was shown to play an 
influential role in the launching, supporting and 
accelerating of IL-23/IL-17 inflammatory signal 
transduction pathway (30). In 2006, Duerr et al. 
indicated a strong relation between Crohn’s disease 
and polymorphisms of the IL23R gene (29). Different 
genotypes of IL23R gene have been evaluated for 
association with chronic inflammatory disorders (31). 
From then, IL23R gene was shown to be an 
influential gene in many other 
autoimmune/inflammatory diseases. Among the 
recognized polymorphisms of IL23R, the functional 
SNP of +2199A/C (rs10889677) located in the 3´-
untranslated region (UTR) has been repeatedly 
shown to be related to different 
autoimmune/inflammatory diseases. However, the 
results are in debate in different diseases. In a study 
from Hungary, the AA genotype of rs10889677 
reported as a risk factor for rheumatoid arthritis (32) 
However, researchers concluded A allele has a 
protective role for ankylosing spondylitis (33). 
Contradictory, some studies indicated that wild type 
C allele increases the risk to Graves’ ophthalmopathy 
(34) and idiopathic dilated cardiomayopathy (35). 
Unfortunately, there is no study on this issue from 
Iran. In the present study we therefore aimed to 
evaluate an association of IL23R +2199A/C 
polymorphism with gastritis, using a case-control 
approach. We also evaluated the association of cagA 
positivity, IL23R +2199A/C polymorphism, and their 
interactions with cellular infiltrations and 
precancerous stages using a case-only approach in a 
population from central area of Iran. 
 
Material and Methods 
A total of 435 patients with nonulcer dyspepsia 
(NUD) who were undergoing upper gastrointestinal 
endoscopy were tested for Hp infection using in-
house RUT. Hp infected and uninfected patients were 
determined by the rapid urease test, PCR 16srRNA, 
urea and histological examination of biopsies taken 
from the corpus. Patients were classified as Hp-
infected only if the three tests were positive and Hp-
uninfected if the three tests were negative, 
respectively. Demographic and clinical data were 
obtained through interview using a standard clinical 
pro forma. Exclusion criteria included history of 
gastric neoplasm or surgery, liver disease, and 
previous treatment with non-steroidal anti-
inflammatory drugs, proton pump inhibitors, 
antibiotics, or bismuth salts. Informed consents for 
participation were signed by all the study subjects. 
The study protocol was approved by the Clinical 
Research Ethics Committee of the Shahrekord 
University of Medical Sciences. 
Histological examination 
Sections of biopsy specimens were embedded 
10 % buffered formalin and stained with 
Hematoxylin and Eosin to examine gastritis and with 
Giemsa to detect Hp. The histological severity of 
gastritis was blindly graded from normal to severe 
based on the grade of PMN and MN infiltration, 
chronic gastritis and chronic active gastritis 
according to the Updated Sydney System (36) on a 
four-point scale: 0, no; 1, mild; 2, moderate; and 3, 
severe changes. 
DNA isolation 
Genomic DNA was extracted from biopsies 
taken from the corpus using Biospin Tissue Genomic 
DNA Extraction Kit (Bio Flux, Japan). All extracted 
DNA was resuspended in UltraPure RNAse/DNAse-
Free Distilled water. 
Genotyping for IL23R +2199A/C (rs10889677) 
polymorphism 
Genotyping analysis IL23R genotyping was 
performed by PCR-RFLP as reported by Chen et al 
(24). Primer sequences for +2199A/C variation of 
IL23R gene are as follows: sense 5´-
AGGGGATTGCTGGGCCATAT-3´, anti-sense 5´-
TGTGCCTGTATGTGTGACCA-3´. The PCR 
amplification was performed in a total volume of 25 
uL mixture containing: 100 ng genomic DNA, 1.0 
mM of each primer, 200 mM of each dNTP, 2.0 mM 
of MgCl2 and 1.0 U Taq DNA polymerase and 10 X 
Taq buffer (Fermentas) using the Biometra Tgradient 
96 (Biometra, Germany). PCR conditions were as 
follows: denaturation at 95 °C for 5 min, followed by 
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38 cycles of 95 °C for 30 s, 60 °C for 45 s, and 72 °C 
for 60 s. A final extension was carried out at 72 °C 
for 10 min and cooling down to 4 °C. The PCR 
products were digested by restriction endonuclease 
MnLI (Fermentas), according to the manufacturer’s 
instructions, at 37°C overnight and then separated by 
10% polyacrylamide gel electrophoresis. Gel analysis 
was performed after staining with ethidium bromide. 
PCR products were shown to be digested into three 
types of fragments (Fig. 1). To confirm the 
genotyping results, selected PCR samples in both 
groups including samples of each genotype were re-
genotyped by other laboratory personnel. There was 
no difference after re-genotyped the randomly 
selected samples. 
 
 
Fig 1: PCR-RFLP polyacrylamide gel electrophoresis 
of the IL23R +2199A/C (rs10889677) polymorphism 
indicating the No.1 (CC = 154, 61 bp), 2,3,4,5 (AC = 
215, 154, 61 bp), 6,7( AA= 215 bp) genotypes. 
 
Determination of cagA ( +/- ) in Hp-infected 
subjects 
Amplification for cagA was performed by 
polymerase chain reaction as reported by Bagheri et 
al (1).Primer sequences for cagA gene are as follows: 
sense 5´ ATGACTAACGAAACTATTGATC-3´, 
anti-sense 5´ CAGGATTTTTGATCGCTTTATT-3´. 
For cagA evaluation, the PCR program comprised 35 
cycles of denaturation (at 94 °C for 30 s), annealing 
(at 56 °C for 30 s, extension at 72 °C for 30 s), and 
one final extension (at 72 °C for 5 min). 
Statistical analysis 
Data were analyzed using SPSS 16.0 (SPSS 
Inc., Chicago, IL). Hardy–Weinberg equilibrium in 
all subjects was analyzed with the x2 goodness-of-fit 
test before the ensuing analyses. The confounding 
effects of age and gender were adjusted using 
conditional logistic regression. Logistic regression 
analyses were used to calculate odds ratios (ORs) and 
95% confidence intervals (CIs) for gastritis in 
association with genotypes. Also Statistical analysis 
was performed by Mann-Whitney Rank Sum test or 
non paired t test depending on the data set. Values of 
p <0.05 were considered as significant. 
 
Results 
Demographic and clinical characteristics 
Genomic DNA was obtained among the193 
(44.4%) Hp-infected and 242(55.6%) Hp-uninfected 
gastritits then the DNA all subjects were genotyped. 
The demographic data of all subjects were 
demonstrated in Table 1. There was no significant 
difference between the two groups with respect to the 
age and gender distribution (p > 0.05) 
 
Table 1: Demographic data of study subjects. 
Variable 
Hp-infected 
(%) 
Hp-
Uninfected 
(%) 
P 
value 
Overall 193(44.4%) 242(55.6%)  
Gender 
Male 
Female 
78(41.9%) 
115(46.2%) 
108(58.1%) 
134(53.8%) 
0.377 
Age 
Mean±SD 
(year) 
47.24 ±17.28 48.29 ±19.49 0.556 
 
IL23R +2199CC genotype and Hp infection 
susceptibility 
The frequencies of the polymorphism in cases 
and controls are shown in Table 2. Frequencies of 
IL23R +2199 genotypes in Hp-infected (CC, 16.8%; 
CA, 37.4% and AA, 45.8%) were different from 
those in Hp-uninfected (CC, 24.8%; CA, 29.2% and 
AA, 46.0%). Compared with AA genotype and CA 
genotype, the CC genotype significantly decreased 
Hp infection risk with ORs of 1.634 (95% CI: 0.985-
2.710). 
IL23R +2199A/C polymorphisms and gastritis 
In our study population, IL23R +2199A/C 
(rs10889677) variants (AA, AC, CC) evaluated in 
Hp-infected and Hp-uninfected population (p > 0.05). 
Carriers of IL23R +2199A/C were not associated 
with chronic active gastritis and chronic gastritis in 
both groups. Also allele C (AC/CC) was not 
associated with risk for gastritis development in both 
group (Table 3 and 4). 
IL23R +2199A/C polymorphisms and cellular 
infiltration 
IL23R+2199A/C genotypes evaluated with 
grade of mononuclear and polymorphonuclear 
infiltration on Hp-infected and Hp-uninfected groups. 
The results are compared in Table 5 and Table 6. 
There was no significant association in both groups 
(p > 0.05). 
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Table 2. Adjusted Odds Ratios (ORs) and 95% confidence intervals (CIs) for Hp-infected in relation to IL23R 
+2199 genotypes 
     
Genotype Hp-infected (%) Hp-Uninfected (%) P value OR# (95% CI) 
IL23R +2199     
AA 82(45.8%) 93(46.0%) 0.523 1.009(0.674-1.511) 
AC 67(37.4%) 59(29.2%) 0.056 0.690(0.449-1.059) 
CC 30(16.8%) 50(24.8%) 0.037 1.634(0.985-2.710) 
# Adjusted for age and gender 
 
Table 3: Odds Ratios (ORs) and 95% Confidence Intervals (CIs) for gastritis in relation to IL23R +2199 genotypes 
in Hp-infected subjects 
IL23R +I2199 Hp-infected (%) Chronic active Gastritis(%) Chronic Gastritis(%) P value OR# (95% CI) 
AA 61(48.8%) 28(42.4%) 33(55.9%) 0.131 0.581(0.286-1.179) 
AC 43(34.4%) 25(37.9%) 18(30.5%) 0.387 1.389(0.660-2.925) 
CC 21(16.8%) 13(19.7%) 8(13.6%) 0.360 1.564(0.598-4.088) 
AC/CC** 64(51.2%) 38(57.6%) 26(44.1%) 0.131 1.723(0.848-3.500) 
# Adjusted for age and gender. 
**C allele, common between homozygote (CC) and heterozygote (AC) situation of IL23R +I2199 polymorphism 
 
Table 4:Odds Ratios (ORs) and 95% Confidence Intervals (CIs) for gastritis in relation to IL23R +2199 genotypes 
in Hp-uninfected subjects 
L23R +I2199 Hp-Uninfected (%) Chronic active Gastritis(%) Chronic Gastritis(%) P value OR# (95% CI) 
AA 28(40.6%) 10(50.0%) 18(36.7%) 0.309 1.722(0.602-4.929) 
AC 24(34.8%) 6(30.0%) 18(36.7%) 0.594 0.738(0.241-2.260) 
CC 17(24.6%) 4(20.0%) 13(26.5%) 0.571 0.692(0.195-2.455) 
AC/CC** 41(59.4%) 10(50.0%) 31(63.3%) 0.309 0.581(0.203-1.662) 
# Adjusted for age and gender. 
**C allele, common between homozygote (CC) and heterozygote (AC) situation of IL23R +I2199 polymorphism 
 
Table 5: Association of IL23R +2199 genotypes with 
cellular infiltrations in Hp-infected subjects 
Genotype No. 
Mononuclear 
infiltration* 
Polymorphonuclear 
infiltration* 
 
IL-23R 
 
AA 
AC 
CC 
 
 
 
66 
46 
22 
1.33 ±0.664(0-3) 
1.38 ±0.733(0-3) 
1.32 ±0.646 (0-
3) 
 
 
 
0.47 ±0.561(0-3) 
0.57 ±0.544(0-3) 
0.55 ±0.510 (0-3) 
P value  0.949 0.556 
*The histopathological parameters were scored as: 0, 
none; 1, mild; 2, moderate; 3, severe 
 
HP cagA positivity, cellular infiltration and 
gastritis 
CagA positivity was comparable among Hp-
infected subjects with PMN and MN infiltration 
(Table 7). Patients with PMN infiltration were 
associated with cagA positivity than were those with 
cagA negativity (p=0.013). However, MN infiltration 
was not associated with cagA positivity among Hp-
infected subjects (p=0.069). Gastritis was significantly 
higher in patients with cagA-positive compared to 
those observed in cagA-negative patients (Table 8), 
then cagA positivity imparted risk for gastritis (p = 
0.044, OR = 2.128, 95% CI = 1.014–4.470). 
 
Table 6:Association of IL23R +2199 genotypes with 
cellular infiltrations in Hp-uninfected subjects 
Genotype No. 
Mononuclearin 
filtration* 
Polymorphonuclear 
infiltration* 
IL-23R 
AA 
AC 
CC 
 
40 
26 
22 
1.02 ±0.832 (0-
3) 
1.27 ±0.667 (0-
3) 
1.18 ±0.853 (0-
3) 
0.28 ±0.506 (0-3) 
0.23 ±0.430 (0-3) 
0.23 ±0.528 (0-3) 
P value  0.388 0.858 
*The histopathological parameters were scored as: 0, 
none; 1, mild; 2, moderate; 3, severe 
 
Table 7:Association of cagA (+/- ) with cellular 
infiltration in Hp-infected subjects 
Genotype No 
Mononuclear 
infiltration* 
Polymorphonuclear 
infiltration* 
 
cagA (+) 
 
96 
 
1.43 ± 0.645 (0-3) 
 
0.60 ± 0.535 (0-3) 
 
cagA (-) 
 
51 
 
1.22 ±0.757 (0-3) 
 
0.37 ±0.528 (0-3) 
 
P value 
 
 
0.069 
 
0.013 
*The histopathological parameters were scored as: 0, 
none; 1, mild; 2, moderate; 3, severe 
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Table 8: Association of cagA ( +/-) with gastritis in 
Hp-infected subjects 
Genotype No. (%) 
Chronic active 
Gastritis(%) 
Chronic 
Gastritis(%) 
cagA (+) 93(68.9%) 55 (76.4%) 38 (60.3%) 
cagA (-) 42(31.1%) 17 (23.6%) 25 (39.7%) 
P value  0.044  
OR# (95% 
CI) 
 
2.128 (1.014-
4.470) 
 
# Adjusted for age and gender. 
 
Discussion 
In the present study we found that frequencies of 
IL23R+2199A/C genotypes and alleles, except for 
genotype CC, were not comparable in infected 
patients and uninfected Hp subjects. IL23R+2199CC 
genotype decreases susceptibility to Hp that may 
indicate Hp infection is associated with pathway of 
IL-23/IL-17 axis. Also, we found that variants of 
IL23R gene, IL23R +2199 CA, IL23R +2199 AA, 
IL23R +2199 CC, were not associated with gastritis in 
Hp-uninfected and Hp-infected patients. These 
findings suggest that IL23R polymorphisms may 
independent of the presence or absence of Hp has no 
effect on chronic active gastritis and chronic gastritis. 
Whereas, one study suggest IL23R +2199CC, 
genotype significantly decreased gastric cancer risk 
and some of IL23R+2199A/C genotypes associated 
with increased risk of certain subtypes of gastric 
cancer, but not with all of them (24). This may 
indicate that the effect of IL23R polymorphism on 
inflammatory processes varied with inflammatory 
Steps. This result is consistent with the different 
mechanisms of inflammation so that in precancerous 
and gastritis stages some of cytokines are dominant 
and have specific role in start of inflammation process 
but as stage Progress, another cytokines participate, 
therefore, we observe many cytokines affection in the 
latter stages. As there is no enough biological report 
that revealed the function of IL23R +2199 
polymorphism, especially in precancerous, it is 
difficult to fully elucidate this phenomenon about our 
study. IL23R+2199A/C allele carrier genotypes were 
not found to be associated with neutrophil and 
lymphocyte infiltration in HP-infected and HP-
uninfected which is consistent with the above. Our 
results may corroborate those of Horvath et al (37)., 
who studies indicate that IL-23 makes a contribution 
to both Th1 and Th17 responses during Hp infection 
especially during the chronic stage of infection (37). 
We suggest that may be an induced inflammatory 
response by Hp that caused by Th1 but not with Th17, 
So IL23R polymorphisms does not affect the 
inflammatory response in our study. Another study 
suggests the presence of CagA contributes to 
regulation of cytokine production in DCsco-cultured 
with Hp in the mouse model of infection, this data 
suggests that IL-23 makes a minor contribution to the 
development of chronic gastritis in this model of Hp 
infection (37). Contradictory, a study from Iran 
reported a higher levels of IL-23 in Hp-infected 
patients (including DU and AS groups) than in the Hp 
negative control group (38). Also studies revealed that 
the inflamed gastric mucosa of Hp-positive patients 
could secrete IL-23 (39). However another study 
reported no significant difference in mucosal IL-17 
and IL-23 mRNA expression between Hp-infected and 
uninfected patients (1) that accordance with our study. 
Gastric mucosa of patients with both duodenal and 
gastric ulcers was equally potent for secretion of IL-23 
compared with patients with chronic active gastritis 
with no signs of peptic ulcer disease. The release of 
IL-23 was greater by Hp-infected gastric mucosa than 
by gastric mucosa not infected by Hp mainly for 
patients with chronic gastritis and only after 
stimulation with LPS. Similar findings have been 
published elsewhere (30, 40). Nevertheless, LPS of 
Hp has also been described to behave in a different 
manner (41). CagA positivity was more frequently 
associated with neutrophil infiltration but we don’t 
found association between cagA positivity and 
lymphocyte infiltration. Also cagA positivity 
correlated with gastritis that shows cagA virulence 
factor may have initiated role in precancerous stages 
especially in chronic active gastritis and chronic 
gastritis. The results of one study also showed that the 
serum levels of IL-23 were not influenced by the cagA 
status of Hp. These results indicate that bacterial 
factors other than cagA may act as inducers of IL-23 
(38). 
In this study in particular, we have demonstrated 
that polymorphism of IL 23R doesn’t play a role in 
control of Hp-induced gastritis. Whether IL23R is an 
independent mediator in the pathogenesis of gastritis 
or not cannot be excluded with safety from the 
presented findings. Further investigation is necessary 
to elucidate fully the exact role of IL23R in the 
pathogenesis of gastritis. Our results highlight the 
importance of cagA virulence factors in explaining 
differential outcomes after infection with Hp. 
However, the importance of host genetic factors rather 
than Hp virulence in explaining variations in 
outcomes after infection in different Asian countries 
has been reported (42). 
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